References

2022 ESC Guidelines on cardio‐oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio‐Oncology Society (IC‐OS)

10.1093/eurheartj/ehac244 · 2022 · External reference

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

10.1016/j.cell.2021.09.020 · 2021 · External reference

Identification of the PROMs used to assess ICI toxicities and HRQoL in patients receiving immune checkpoint inhibitor treatment in cancer care and their suitability: a systematic review

10.1016/j.ctrv.2024.102862 · 2025 · External reference

Safety and efficacy of the rechallenge of immune checkpoint inhibitors after immune‐related adverse events in patients with cancer: a systemic review and meta‐analysis

10.3389/fimmu.2021.730320 · 2021 · External reference

Immune checkpoint inhibition perturbs neuro‐immune homeostasis and impairs cognitive function

10.1186/s13046-025-03442-3 · 2025 · External reference

Myocarditis in patients treated with immune checkpoint inhibitors

10.1016/j.jacc.2018.02.037 · 2018 · External reference

Case series of steroid‐resistant immune checkpoint inhibitor associated myocarditis: a comparative analysis of corticosteroid and tofacitinib treatment

10.3389/fphar.2021.770631 · 2021 · External reference

Reversal of immune‐checkpoint inhibitor fulminant myocarditis using personalized‐dose‐adjusted abatacept and ruxolitinib: proof of concept

10.1136/jitc-2022-004699 · 2022 · External reference

Steroid‐refractory myocarditis induced by immune checkpoint inhibitor responded to infliximab: report of two cases and literature review

10.1007/s12012-024-09918-6 · 2024 · External reference

Multiplatform approach for plasma proteomics: complementarity of Olink proximity extension assay technology to mass spectrometry‐based protein profiling

10.1021/acs.jproteome.0c00641 · 2021 · External reference

A blood‐based multi‐pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups

10.1002/alz.13676 · 2024 · External reference

Targeted plasma proteomics reveals organ damage signatures of AIDS‐ and noncommunicable disease‐related deaths in people with HIV

10.1038/s41467-025-59242-y · 2025 · External reference

The plasma proteome in community‐acquired pneumonia: pathophysiology, outcome and 10‐year risk

10.1164/rccm.202502-0325oc · 2025 · External reference

Olink profiling of intestinal tissue identifies novel biomarkers for colorectal cancer

10.1021/acs.jproteome.4c00728 · 2025 · External reference

Chinese expert consensus on the surveillance and management of immune checkpoint inhibitor‐related myocarditis (2020 version)

2020 · External reference

CSCO Clinical Practice Guidelines for Cardio‐Oncology

2023 · External reference

Chinese guideline on the diagnosis and treatment of fulminant myocarditis in adults

2024 · External reference

Immune responses in checkpoint myocarditis across heart, blood and tumour

10.1038/s41586-024-08105-5 · 2024 · External reference

Expansion of pathogenic cardiac macrophages in immune checkpoint inhibitor myocarditis

10.1161/circulationaha.122.062551 · 2024 · External reference

Identification and validation of diagnostic biomarkers of coronary artery disease progression in type 1 diabetes via integrated computational and bioinformatics strategies

10.1016/j.compbiomed.2023.106940 · 2023 · External reference

Identifying potential targets for preventing cancer progression through the PLA2G1B recombinant protein using bioinformatics and machine learning methods

10.1016/j.ijbiomac.2024.133918 · 2024 · External reference

Predicting the molecular mechanism of ginger targeting PRMT1/BTG2 axis to inhibit gastric cancer based on WGCNA and machine algorithms

10.1016/j.phymed.2025.156892 · 2025 · External reference

Overview of LASSO‐related penalized regression methods for quantitative trait mapping and genomic selection

10.1007/s00122-012-1892-9 · 2012 · External reference

Constructing bi‐plots for random forest: tutorial

10.1016/j.aca.2020.06.043 · 2020 · External reference

SVM‐RFE based feature selection and Taguchi parameters optimization for multiclass SVM classifier

10.1155/2014/795624 · 2014 · External reference

Pathological mechanisms and treatment strategies for immune checkpoint inhibitor‐associated myocarditis: insights from single‐cell sequencing

10.1007/s00395-025-01156-3 · 2026 · External reference

Novel therapeutic approach targeting CXCR3 to treat immunotherapy myocarditis

10.1161/circresaha.124.325652 · 2025 · External reference

CXCL9 chemokine in ulcerative colitis

2018 · External reference

CXCL9 as a novel prognostic marker to identify high‐risk adults with hemophagocytic lymphohistiocytosis

10.1182/blood.2025030976 · 2026 · External reference

Rheumatoid arthritis and the Th1 chemokine MIG

2019 · External reference

Type 1 helper T cells generate CXCL9/10‐producing T‐bet(+) effector B cells potentially involved in the pathogenesis of rheumatoid arthritis

10.1016/j.cellimm.2020.104263 · 2021 · External reference

Distinct inflammation‐related proteins associated with T cell immune recovery during chronic HIV‐1 infection

10.1080/22221751.2022.2150566 · 2023 · External reference

TNFSF11/TNFRSF11A axis amplifies HDM‐induced airway remodeling by strengthening TGFβ1/STAT3 action

10.4168/aair.2024.16.4.399 · 2024 · External reference

Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage

10.1186/s11658-022-00365-1 · 2022 · External reference

Glucocorticoid receptor regulates TNFSF11 transcription by binding to glucocorticoid responsive element in TNFSF11 proximal promoter region

10.3390/ijms22031054 · 2021 · External reference

Identification of potential immunotherapy biomarkers for breast cancer by bioinformatics analysis

10.1042/bsr20212035 · 2022 · External reference

Senescent lung fibroblasts in idiopathic pulmonary fibrosis facilitate non‐small cell lung cancer progression by secreting exosomal MMP1

10.1038/s41388-024-03236-5 · 2025 · External reference

Integrated multidimensional bioinformatics analysis of the molecular mechanisms of ulcerative colitis‐associated colorectal cancer and MMP1 as a potential therapeutic target

10.1038/s41417-025-00917-5 · 2025 · External reference

SPHK1 promotes HNSCC immune evasion by regulating the MMP1‐PD‐L1 axis

10.7150/thno.102390 · 2024 · External reference

Multiple biomarkers for the prediction of first major cardiovascular events and death

10.1056/nejmoa055373 · 2006 · External reference

Therapeutic agents for steroid‐refractory immune checkpoint inhibitor‐related myocarditis: a narrative review

10.21037/cdt-24-114 · 2024 · External reference

Anti‐inflammatory activity of IVIG mediated through the inhibitory Fc receptor

10.1126/science.291.5503.484 · 2001 · External reference

Tofacitinib: a review in rheumatoid arthritis

10.1007/s40265-017-0835-9 · 2017 · External reference

Therapeutic effects of tofacitinib on steroid‐resistant immune checkpoint inhibitor‐associated myocarditis

2024 · External reference